Hepatic resection is the optimal treatment for patients with hepatocellular carcinoma (HCC) in the very early or early stage [Barcelona Clinic Liver Cancer (BCLC)0/A]. However, recurrence within 2 years occurs in 30%–50% of patients; hence, HCC is the major cause of mortality. This study aimed to develop and validate a clinical model to predict the early recurrence of HCC after curative resection. The proposed nomogram provided better discrimination than the BCLC stage and AJCC-TNM (eight edition).
How to access this content:
For one year after publication, abstracts and videos are only open to registrants of this annual meeting. Registrants should use their existing login information. Non-registrant access can be purchased via the ISMRM E-Library.
After one year, current ISMRM & ISMRT members get free access to both the abstracts and videos. Non-members and non-registrants must purchase access via the ISMRM E-Library.
After two years, the meeting proceedings (abstracts) are opened to the public and require no login information. Videos remain behind password for access by members, registrants and E-Library customers.
Keywords